Summit Therapeutics (SMMT) EBITDA (2017 - 2024)
Summit Therapeutics (SMMT) recorded EBITDA of -$65.59 million in Q4 2024, compared with -$36.18 million a year earlier.
Powered by 
Analysis
Summit Therapeutics (SMMT) EBITDA (2017 - 2024) Analysis & Trends
For FY2024, Summit Therapeutics reported EBITDA of -$225.91 million.
- Across earlier years, EBITDA came in at -$609.45 million in FY2023, -$70.83 million in FY2022, -$84.84 million in FY2021 and -$51.64 million in FY2020.
- The Q4 2024 figure is the lowest quarterly EBITDA since Q1 2023.
- Per Business Quant, the preceding three quarters came in at -$58.36 million (Q3 2024), -$59.6 million (Q2 2024) and -$42.36 million (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Summit Therapeutics | 12.33 Bn | 10.09 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -65.59 Mn |
| Sep 30, 2024 | -58.36 Mn |
| Jun 30, 2024 | -59.60 Mn |
| Mar 31, 2024 | -42.36 Mn |
| Dec 31, 2023 | -36.18 Mn |
| Sep 30, 2023 | -20.46 Mn |
| Jun 30, 2023 | -15.75 Mn |
| Mar 31, 2023 | -537.06 Mn |
| Dec 31, 2022 | -19.99 Mn |
| Sep 30, 2022 | -16.63 Mn |
| Jun 30, 2022 | -12.36 Mn |
| Mar 31, 2022 | -21.84 Mn |
| Dec 31, 2021 | -25.72 Mn |
| Sep 30, 2021 | -19.15 Mn |
| Jun 30, 2021 | -23.38 Mn |
| Mar 31, 2021 | -16.59 Mn |
| Dec 31, 2020 | -11.10 Mn |
| Sep 30, 2020 | -16.54 Mn |
| Jun 30, 2020 | -15.03 Mn |
| Mar 31, 2020 | -20.32 Mn |
API Access
Summit Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=SMMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "SMMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=SMMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();